Navigation Links
Court Preliminarily Deems Millennium Laboratories' Press Release 'Misleading'
Date:6/14/2012

BALTIMORE, June 14, 2012 /PRNewswire/ -- Ameritox(SM), the nation's leader in pain medication monitoring, announced today that the Baltimore, MD, Federal Court issued a Preliminary Injunction order against Millennium Laboratories for misleading statements contained within a Millennium Laboratories press release.  The Preliminary Injunction confirms the court's initial concerns about the Millennium Laboratories press release that led to its issuance of the Temporary Restraining Order on Wednesday, June 13, and moves from a temporary restriction to enjoining Millennium Laboratories' action regarding the press release. Following is the language directly from the Preliminary Injunction issued by the Court on Thursday, June 14, 2012:

"On June 13, 2012, Millennium and Ameritox entered into, and the Court approved, a Consent Order that concluded the above-captioned Lanham Act case. Docket No. 321. Later the same day, Millennium issued a press release (the "Press Release") concerning the litigation and the Consent Order. Docket No. 306-1. Upon motion by Ameritox, the Court granted a Temporary Restraining Order requiring, inter alia, that Millennium take down the Press Release from its web site, and enjoining Millennium's sales representatives from using the Press Release in sales presentations or communications. Docket No. 329.

On June 14, 2012, the Court reviewed written submissions from both sides and convened a sealed hearing. For reasons that the Court stated on the record, the undersigned granted Ameritox's motion to convert the Temporary Restraining Order to a Preliminary Injunction (Docket No. 324).1 This order effectuates that ruling.

To set the record straight, the Court will publish a brief opinion stating clearly the advertisements that were accused under the Lanham Act, the grounds upon which the advertisements were accused, the evidentiary limitations imposed by the Court, the recommendations of the advisory jury, and the rulings of the Court. The Court will issue this opinion as soon as practicable.

Until the Court can write the opinion and review it with counsel, the interests of justice require that Millennium be enjoined from distributing the Press Release or using it in sales presentations. Hence, the Court is issuing this preliminary injunction.

As the Court explained during today's hearing, a preliminary injunction is warranted under the standard articulated in Winter v. Natural Resources Defense Council, Inc., 555 U.S. 7, 20 (2008). Moreover, the Court has inherent authority to enjoin misleading statements concerning litigation before it. See Am. Sci. & Eng'g, Inc. v. Autoclear, LLC, 606 F. Supp. 2d 617, 626 (E.D. Va. 2008) (orderingremoval of a press release that contained misleading statements about the court's rulings).2

The Court is not enjoining all communication by the parties regarding this litigation, but only the Press Release that the Court has, on the basis of the record before it, preliminarily deemed to be misleading. The injunction is, therefore, appropriately tailored. See Cornwell v. Sachs, 99 F. Supp. 2d 695, 708 (E.D.Va. 2000).

For the foregoing reasons, it is this 14th Day of June, 2012, hereby ORDERED as follows:

1. The Temporary Restraining Order issued on June 13, 2012 (Docket No. 329) is VACATED;

2. Millennium shall remove the Press Release from its web site; and

3. Pending further Order of Court, Millennium is preliminarily enjoined from using the Press Release in sales presentations or communications or otherwise disseminating it to the public.

About Ameritox

Ameritox is the nation's leader in Pain Medication Monitoring Solutions®, offering specialized laboratory testing and reporting services. Ameritox's expertise and innovative science provide physicians with insights and support to enhance and optimize the care of chronic pain patients. Ameritox offers the most thorough pain medication monitoring lab process – Rx Guardian(SM) – with Rx Guardian CD(SM), the only pain medication screening with a proprietary normalization algorithm and a reference database of pain patients assessed for medication adherence. Patient results are compared against this database, helping physicians assess whether patients are taking their pain medications correctly. Monitoring through urine drug testing helps physicians make more informed clinical decisions and manage the risks and complexities associated with prescribing pain medications. Ameritox is headquartered in Baltimore, Md. with laboratory facilities in Midland, Texas and Greensboro, N.C. Ameritox can be found online at www.ameritox.com, on Twitter @Ameritox, or on Facebook at facebook.com/ameritox.

© 2012 Ameritox Ltd. All rights reserved. AMERITOX, the AMERITOX logos, AMERITOX AUTOREMINDER, AMERITOX MEDICATION MONITORING SOLUTIONS, AMERITOX UNIVERSITY, PAIN MEDICATION MONITORING SOLUTIONS, POWERED BY YOUR NEED TO KNOW and PROTECT YOUR PATIENTS. PROTECT YOUR PRACTICE. RX GUARDIAN, RX GUARDIAN CD, and RX GUARDIAN AUTOREMINDER are trademarks of Ameritox.

 

Contact:

Lon Wagner
Director of Communications
336-387-7742


'/>"/>
SOURCE Ameritox Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Millennium Surgical Corp. Develops Online Sterilization Resource Center
2. Millennium Surgical Corp. Announces Sales Figures, Growth
3. Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences
4. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
5. Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories
6. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
7. Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc.
8. New Data Support Role of Prometheus Laboratories Novel Assay in Optimizing IBD Treatment Management
9. Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation
10. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
11. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... and Consulting, LLC , and named its founder as ... in Tennessee , will operate under ... EnvoyHealth,s service offerings for health care partners to include ... "In an interoperable world, technology delivers ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for ... for action towards gender equality at their inaugural Summit in New York City in ... reached a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented ... the lowdown on sciatica in a new episode of "Success Files," which is ... events and innovation and investigates each subject in-depth with passion and integrity. , ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics ... PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... of Morris F. Collen, a pioneer in the field of medical informatics, this prestigious ...
Breaking Medicine News(10 mins):